论文部分内容阅读
目的探讨全胸腔镜支气管袖式肺叶切除术治疗中央型肺癌的疗效及安全性。方法中央型非小细胞肺癌患者30例,9例采用全胸腔镜支气管袖式肺叶切除术(微创组),21例行开胸支气管袖式肺叶切除术(开胸组)。比较两组手术相关资料、术后疼痛评分及并发症发生情况。结果两组肿瘤直径、淋巴结总数、淋巴结组数、病理类型、病理分期、肺切除类型、手术时间、术中出血量及胸腔引流量比较差异均无统计学意义(P>0.05)。与开胸组比较,微创组术后1d及3d疼痛评分较低(P<0.05)。微创组患者胸腔引流置管时间和术后住院时间均短于开胸组(P<0.05)。术后并发症:开胸组8例,微创组2例。结论全胸腔镜支气管袖式肺叶切除术治疗中央型肺癌安全、可行,较开胸手术患者术后疼痛轻、住院时间短。
Objective To investigate the efficacy and safety of total thoracoscopic bronchial sleeve lobectomy in the treatment of central lung cancer. Methods Thirty patients with central non-small cell lung cancer were enrolled. Nine patients underwent thoracoscopic bronchial sleeve lobectomy (minimally invasive group) and 21 underwent thoracotomy bronchial sleeve lobectomy (thoracotomy group). The surgical data, postoperative pain scores and complications were compared between the two groups. Results There were no significant differences in tumor diameter, total lymph nodes, lymph node number, pathological type, pathological stage, type of lung resection, operation time, intraoperative blood loss and drainage of thoracic cavity between the two groups (P> 0.05). Compared with the thoracotomy group, the pain scores of the minimally invasive group at 1 day and 3d were lower (P <0.05). Patients in the minimally invasive group had shorter chest drainage and postoperative hospital stay than those in the thoracotomy group (P <0.05). Postoperative complications: thoracotomy group of 8 patients, minimally invasive group of 2 patients. Conclusion Thoracoscopic bronchial sleeve lobectomy for the treatment of central lung cancer is safe and feasible. Compared with thoracotomy, the patients have less postoperative pain and shorter hospital stay.